
ADA’s Standards of Care are the gold standard for diabetes care and prevention that allows clinicians around the world to remain abreast of the rapidly changing healthcare landscape,” said Dr. “Evidence-based recommendations drive better care for all people with diabetes, including vulnerable communities and those at high risk.

The role of finerenone in individuals with diabetes and chronic kidney disease with albuminuria.

The expanded role of SGLT2 inhibitor use in preserved and reduced heart failure ejection fraction.New hypertension diagnosis cut-offs (hypertension is now defined as a systolic blood pressure ≥130 mmHg or a diastolic blood pressure ≥80 mmHg).Broad consideration of social determinants of health in guiding the design and delivery of care.New recommendations related to sleep health and physical activity in people with diabetes.Emphasis on supporting higher weight loss (up to 15%) based on the efficacy of and access to newer medications when appropriate.Notable updates to the Standards of Care in Diabetes─2023include:

This guidance will ensure health care teams, clinicians and researchers treat the whole person.”

“This year’s annual report provides necessary guidance that considers the role health inequities play in the development of diabetes, particularly for vulnerable communities and communities of color disproportionately impacted by the disease. “ADA’s mission is to prevent and cure diabetes, a chronic illness that requires continuous medical care, and the release of ADA’s Standards of Care is a critical part of that mission,” said Chuck Henderson, chief executive officer for the ADA. Based on the latest scientific research and clinical trials, the Standards of Care includes vital new and updated practice guidelines to care for people with diabetes and prediabetes, including for the diagnosis and treatment of youth and adults with type 1, type 2, or gestational diabetes strategies for the prevention or delay of type 2 diabetes and associated comorbidities and therapeutic approaches that can reduce complications, mitigate cardiovascular and renal risk, and improve health outcomes. Today, the American Diabetes Association ® (ADA) published Standards of Care in Diabetes-2023 (Standards of Care), comprehensive, evidence-based guidelines for the prevention, diagnosis, and treatment of diabetes. New guidelines include updates to recommendations around obesity, hypertension, heart failure medication, social determinants of health, and lipid management
